Docetaxel and carboplatin is an active regimen in advancednon-small-cell lung cancer: a phase II study in Caucasian and Asian patients
Michael Millward(University of Western Australia), James F. Bishop, Danny Rischin(Peter MacCallum Cancer Centre), M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), Edward McNeil, Michael Boyer(Chris O’Brien Lifehouse), Justin Wong(National University Hospital), Stephen Clarke(The University of Sydney), Boon Cher Goh(National University of Singapore)
Cited by 106
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k